tradingkey.logo

TELA Bio Inc

TELA
1.130USD
-0.010-0.88%
收盤 12/19, 16:00美東報價延遲15分鐘
45.59M總市值
虧損本益比TTM

TELA Bio Inc

1.130
-0.010-0.88%

關於 TELA Bio Inc 公司

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc簡介

公司代碼TELA
公司名稱TELA Bio Inc
上市日期Nov 08, 2019
CEOKoblish (Antony)
員工數量209
證券類型Ordinary Share
年結日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編19355
電話14843202930
網址https://www.telabio.com/
公司代碼TELA
上市日期Nov 08, 2019
CEOKoblish (Antony)

TELA Bio Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.93K
--
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. William Plovanic
Mr. William Plovanic
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
業務USD
名稱
營收
佔比
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
其他
49.38%
持股股東
持股股東
佔比
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
其他
49.38%
股東類型
持股股東
佔比
Hedge Fund
33.32%
Venture Capital
17.62%
Investment Advisor
9.79%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
8.59%
Research Firm
1.77%
其他
20.24%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
171
28.74M
72.54%
-9.88M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
EW Healthcare Partners
4.11M
10.38%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
5.11M
12.9%
-1.00
-0.00%
Jun 30, 2025
North Run Capital, LP
3.68M
9.3%
+1.70M
+85.75%
Mar 31, 2025
Lytton (Laurence W)
2.72M
6.88%
+271.93K
+11.09%
Jun 30, 2025
SilverArc Capital Management, LLC
2.78M
7.02%
+8.51K
+0.31%
Jun 30, 2025
Stonepine Capital Management, LLC
2.08M
5.26%
+28.54K
+1.39%
Jun 30, 2025
The Vanguard Group, Inc.
1.91M
4.83%
-16.59K
-0.86%
Jun 30, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Jun 30, 2025
Perkins Capital Management, Inc.
875.87K
2.21%
-34.75K
-3.82%
Jun 30, 2025
Citi Investment Research (US)
750.00K
1.89%
--
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

TELA Bio Inc的前五大股東是誰?

TELA Bio Inc的前五大股東如下:
EW Healthcare Partners
持有股份:4.11M
佔總股份比例:10.38%。
Nantahala Capital Management, LLC
持有股份:5.11M
佔總股份比例:12.90%。
North Run Capital, LP
持有股份:3.68M
佔總股份比例:9.30%。
Lytton (Laurence W)
持有股份:2.72M
佔總股份比例:6.88%。
SilverArc Capital Management, LLC
持有股份:2.78M
佔總股份比例:7.02%。

TELA Bio Inc的前三大股東類型是什麼?

TELA Bio Inc 的前三大股東類型分別是:
EW Healthcare Partners
Nantahala Capital Management, LLC
North Run Capital, LP

有多少機構持有TELA Bio Inc(TELA)的股份?

截至2025Q3,共有171家機構持有TELA Bio Inc的股份,合計持有的股份價值約為28.74M,占公司總股份的72.54% 。與2025Q2相比,機構持股有所增加,增幅為-11.90%。

哪個業務部門對TELA Bio Inc的收入貢獻最大?

在FY2025Q2,OviTex業務部門對TELA Bio Inc的收入貢獻最大,創收24.60M,占總收入的63.53% 。
KeyAI